Skip to main content Accessibility help
×
Home

Contents:

Information:

  • Access

Figures:

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        Effect of increasing doses of long chain n−3 PUFA on vascular function: MARINA – a randomised controlled trial
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        Effect of increasing doses of long chain n−3 PUFA on vascular function: MARINA – a randomised controlled trial
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        Effect of increasing doses of long chain n−3 PUFA on vascular function: MARINA – a randomised controlled trial
        Available formats
        ×
Export citation

Dietary EPA and DHA intakes have been positively associated with improved endothelial function in young adults(1). However, Egert et al.(2) reviewed thirty-three intervention trials investigating the effects of n−3 PUFA on fasting and/or postprandial endothelial function and no clear conclusion could be drawn because of the small numbers in many trials and inconsistent methodology. The MARINA study (ISRCTN66664610) was a randomised controlled trial designed to test the hypothesis that increasing doses of EPA and DHA (0.45 g, 0.9 g and 1.8 g/d; equivalent to consuming 1, 2 or 4 portions of oily fish per week) taken for 1 year have favourable effects on endothelial function measured by flow-mediated dilatation (FMD) of the brachial artery. EPA+DHA and placebo (olive oil BP) were administered as supplements and the study was conducted double blind. A total of 367 non-smoking participants (142 men, 225 women aged 45–70 years, mean age 55 years) were randomised to treatment and a total of 312 subjects completed; data was available for analysis on 311 subjects for baseline and follow-up measurements of endothelial function. The mean (95% CI) increase in erythrocyte EPA compared with placebo was 0.74 (0.56–0.91), 1.31 (1.13–1.48) and 2.51 (2.33–2.69) wt % on 0.45 g/d, 0.9 g/d and 1.8 g/d, respectively (P<0.0001). Significant reductions in plasma TAG concentrations (P=0.002) were observed in women but not men: in comparison with placebo changes were −0.06 (−0.21 to 0.09), −0.12 (−0.27 to 0.03) and −0.29 (−0.44 to −0.14) mmol/l on doses of 0.45, 0.9 and 1.8 g/d, respectively. No significant treatment effects were noted for ambulatory blood pressure or arterial stiffness (pulse wave velocity). FMD was lower in men than in women (P<0.0001) and decreased with age (ρ=0.270; P<0.001) but there were no statistically significant treatment effects (P=0.781).

Our results are consistent with a cross-sectional survey in 3045 adults(3) that found no significant relationship between the n−3 LCP intake with FMD but a trend for FMD to be 0.1 and 0.27% lower on the highest compared with lowest intake in men and women, respectively. Our results indicate that intakes of n−3 LCP up to 1.8 g/d do not influence endothelial function in healthy non-smoking adults at moderate risk of CVD.

Funding for this work was provided by the Food Standards Agency and the Department of Health, England (Project code N02041).

1.Leeson, CP, Mann, A & Kattenhorn, M (2002) Eur Heart J 23, 216222.
2.Egert, S & Stehle, P (2011) Curr Opin Clin Nutr Metab Care 14, 121–31.
3.Anderson, JS, Nettleton, JA, Herrington, DM et al. (2010) Am J Clin Nutr 92, 12041213.